Exchange: NASDAQ·Updated 07:30 PM EDT
JANX logo

JANX Janux Therapeutics Inc

$18.86
$0.67
(3.68%)
Today
Closed $18.89
$0.03
(0.16%)
After Hours
Reported EarningsAug 6
Mkt Cap$1.11B
Vol980,544.00

About JANX

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
61

Bullish Sentiment

How do you feel about JANX?

Advertisement|Remove ads.